Neuronetics Inc. 1 article published in JoVE Neuroscience The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression Jared C. Horvath1, John Mathews2, Mark A. Demitrack2, Alvaro Pascual-Leone1 1Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, 2Neuronetics, Inc. In this article, we examine the methodology and considerations relevant to the FDA approved depression treatment protocol using the Neuronetics NeuroStar TMS device.